Pulmatrix, Inc. — Investor Relations & Filings
Pulmatrix, Inc. is a clinical-stage biopharmaceutical company that develops novel inhaled therapeutic products for respiratory and other diseases. The company's core is its proprietary iSPERSE™ technology, an engineered dry powder platform designed for efficient drug delivery directly to the lungs. This technology aims to improve therapeutic outcomes for patients with serious pulmonary conditions. The company's development pipeline has included candidates for diseases such as Chronic Obstructive Pulmonary Disease (COPD). In late 2024, Pulmatrix announced a proposed merger with Cullgen Inc., a company focused on targeted protein degradation, to form a combined entity with a diversified clinical pipeline.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Pulmatrix, Inc. (0001574235) (Filer) | 2026-04-21 | English | |
| 8-K - PULMATRIX, INC. (0001574235) (Filer) | 2026-03-02 | English | |
| 10-K - PULMATRIX, INC. (0001574235) (Filer) | 2026-02-26 | English | |
| 8-K - PULMATRIX, INC. (0001574235) (Filer) | 2026-02-26 | English | |
| 8-K | 2025-12-18 | English | |
| 10-Q | 2025-10-16 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 34759524 | 8-K - Pulmatrix, Inc. (0001574235) (Filer) | 2026-04-21 | English | ||
| 32894241 | 8-K - PULMATRIX, INC. (0001574235) (Filer) | 2026-03-02 | English | ||
| 32894243 | 10-K - PULMATRIX, INC. (0001574235) (Filer) | 2026-02-26 | English | ||
| 32894242 | 8-K - PULMATRIX, INC. (0001574235) (Filer) | 2026-02-26 | English | ||
|
2025
11 filings
| |||||
| 12656877 | 8-K | 2025-12-18 | English | ||
| 12656878 | 10-Q | 2025-10-16 | English | ||
| 12656879 | 8-K | 2025-10-16 | English | ||
| 12656882 | 10-Q | 2025-08-06 | English | ||
| 12656881 | 8-K | 2025-08-06 | English | ||
| 12656883 | 8-K | 2025-06-16 | English | ||
| 30651016 | 425 Filing | 2025-06-16 | English | ||
| 12656884 | 10-Q | 2025-05-15 | English | ||
| 12656886 | 8-K | 2025-05-15 | English | ||
| 12656885 | Regulatory Filings 2025 | 2025-05-12 | English | ||
| 12656888 | 424B3 | 2025-05-09 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
Pulmatrix, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35037/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35037 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35037 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35037 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35037}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Pulmatrix, Inc. (id: 35037)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.